This company listing is no longer active
6HL0 Stock Overview
Provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for 6HL0 from our risk checks.
R1 RCM Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$13.40 |
| 52 Week High | US$13.40 |
| 52 Week Low | US$8.10 |
| Beta | 0.84 |
| 11 Month Change | 3.08% |
| 3 Month Change | 7.20% |
| 1 Year Change | 36.04% |
| 33 Year Change | -40.18% |
| 5 Year Change | 16.32% |
| Change since IPO | 27.26% |
Recent News & Updates
Recent updates
Shareholder Returns
| 6HL0 | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | 0% | 1.1% | 0.2% |
| 1Y | 36.0% | 16.5% | 8.5% |
Return vs Industry: 6HL0 exceeded the German Healthcare industry which returned 18% over the past year.
Return vs Market: 6HL0 exceeded the German Market which returned 7.9% over the past year.
Price Volatility
| 6HL0 volatility | |
|---|---|
| 6HL0 Average Weekly Movement | 1.3% |
| Healthcare Industry Average Movement | 4.1% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.9% |
| 10% least volatile stocks in DE Market | 2.3% |
Stable Share Price: 6HL0 has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: 6HL0's weekly volatility has decreased from 6% to 1% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | 29,650 | Lee Rivas | www.r1rcm.com |
R1 RCM Inc. provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers. The company also offers modular solutions, including functional partnership, an outsourcing solutions for improvements across targeted revenue cycle areas for hospital and physician group customers; revenue recovery, to fast-track payer and patient cash collections; revenue optimization, a solution to uncover missed or underreported revenue; clinical integrity, used to improve documentation and coding accuracy to maximize earned revenue for the services provided; and regulatory navigation, a compliance-first solutions for government reimbursement accuracy, pharmacy savings, and compliance.
R1 RCM Inc. Fundamentals Summary
| 6HL0 fundamental statistics | |
|---|---|
| Market cap | €5.70b |
| Earnings (TTM) | -€57.76m |
| Revenue (TTM) | €2.33b |
2.5x
P/S Ratio-98.8x
P/E RatioIs 6HL0 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 6HL0 income statement (TTM) | |
|---|---|
| Revenue | US$2.46b |
| Cost of Revenue | US$1.99b |
| Gross Profit | US$472.70m |
| Other Expenses | US$533.90m |
| Earnings | -US$61.20m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.14 |
| Gross Margin | 19.19% |
| Net Profit Margin | -2.48% |
| Debt/Equity Ratio | 78.6% |
How did 6HL0 perform over the long term?
See historical performance and comparison